Active Filter(s):
Details:
The two organizations will collaborate to advance the development of radiopharmaceuticals to accelerate new and emerging cancer diagnostics and treatments.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Undisclosed
Partner/Sponsor/Collaborator: PharmaLogic
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration May 15, 2023